Literature DB >> 18116227

Hemolytic anemias recent advances in diagnosis and treatment.

R S EVANS, R DUANE.   

Abstract

THE HEMOLYTIC ANEMIAS OF UNKNOWN CAUSE CAN BE SEPARATED INTO TWO MAIN GROUPS: (1) those produced by a defect in cell structure, which is usually hereditary, and (2) those due to a hemolysin of immune-body type.The hemolytic anemias associated with hypersensitivity to drugs and disease processes such as leukemia are less well understood and need further investigation. Splenectomy is the only effective treatment in congenital hemolytic jaundice and in acquired hemolytic anemia; the operation should be carried out promptly in most cases. Transfusion may be used in all varieties of hemolytic disease and is the only effective form of therapy in sickle-cell anemia and paroxysmal nocturnal hemoglobinuria.

Entities:  

Keywords:  ANEMIA/hemolytic

Mesh:

Substances:

Year:  1949        PMID: 18116227      PMCID: PMC1643779     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  1 in total

1.  A New Antibody in Serum of Patients With Acquired Hemolytic Anemia.

Authors:  P Sturgeon
Journal:  Science       Date:  1947-09-26       Impact factor: 47.728

  1 in total
  1 in total

1.  Acute idiopathic haemolytic anemia.

Authors:  J G MILLICHAP
Journal:  Arch Dis Child       Date:  1952-06       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.